GLP-1 receptor agonists actively revolutionize obesity and Type-2 diabetes treatments by mimicking natural gut hormones to suppress appetite and control blood sugar. Despite profound cardiometabolic benefits, rapid weight loss triggers adverse effects, prompting strict global regulatory crackdowns against unauthorized usage.
Click to View More
© 2026 iasgyan. All right reserved
